💰Economy & data
AstraZeneca stock drops 9% after heart drug trial miss deals rare blow to pharma powerhouse
No AI summary yet. Want one? (Free, takes a few seconds.)
This summary is an AI hot-take based on the headline. It can miss nuance, so please tap through to the original for the actual story 🙏
Read the real thing · CNBC — Top News ↗How does this feel?